NVO Stock: Strong Sales Growth Amid Market Challenges – A Data Analyst's Perspective Ozempic's Maker Isn't Exactly BoomingNovo Nordisk (NVO) just dropped its Q3 numbers, and the headline looks decent enough: a 15% jump in sales a...
